Re: Chart is looking good....
|
3
|
Resverlogix Corp.
|
Aug 12, 2016 01:22PM
|
Re: By Christmas time.....
|
10
|
Resverlogix Corp.
|
Dec 09, 2020 04:15PM
|
Re: Buyers need sellers....why I think delivery failures are important
|
3
|
Resverlogix Corp.
|
Nov 09, 2019 01:36PM
|
Re: BMO Current Value at 0
|
4
|
Zenith Epigenetics
|
Oct 31, 2018 02:15PM
|
Re: BIO CEO Slides Up
|
3
|
Zenith Epigenetics
|
Feb 14, 2019 09:17AM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
7
|
Resverlogix Corp.
|
Sep 24, 2017 04:41PM
|
Re: Be careful what you wish for.....short interest and Zenith IPO thoughts.
|
6
|
Resverlogix Corp.
|
Dec 04, 2015 11:22AM
|
Re: AMRN Adcom
|
3
|
Resverlogix Corp.
|
Aug 09, 2019 01:40PM
|
Re: Also interesting, but less encouraging
|
11
|
Resverlogix Corp.
|
Aug 04, 2022 02:45PM
|
Re: AHA NEWS
|
7
|
Resverlogix Corp.
|
Sep 23, 2019 07:25PM
|
Re: AGM - Jan 7, 2016 - Details
|
3
|
Zenith Epigenetics
|
Jan 15, 2016 09:24AM
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Jun 10, 2019 08:27PM
|
Re: ... unfinished business
|
5
|
Zenith Epigenetics
|
Nov 02, 2018 06:00PM
|
Protecting shares from being borrowed by shorts
|
4
|
Resverlogix Corp.
|
May 18, 2018 11:37AM
|
Presentation at BIO 2016
|
3
|
Resverlogix Corp.
|
Jun 07, 2016 02:37PM
|
Phase III - Where will it take place
|
4
|
Resverlogix Corp.
|
Sep 07, 2015 06:14PM
|
Pfizer's PCSK9 Inhibitor bococizumab - further development being scrapped
|
5
|
Resverlogix Corp.
|
Nov 01, 2016 11:17AM
|
Pfizer vs J&J - Nonmetastatic prostate cancer
|
1
|
Zenith Epigenetics
|
Feb 06, 2018 09:54AM
|
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)
|
4
|
Zenith Epigenetics
|
Dec 14, 2016 04:34PM
|
PAH Plans get a write up in Pulmonary Hypertension News
|
7
|
Resverlogix Corp.
|
May 21, 2019 08:34AM
|